SkyMedAI is an advisory practice led by Dr. Amir Lahav, bringing together 25+ years of leadership with a trusted network of clinicians, scientists, and industry leaders shaping the future of health.
We turn AI vision and clinical innovation into market success, from early strategy through commercialization and scale. We specialize in clinical validation and AI guardrails for medical-grade and consumer health solutions.
• Investors
• Health Systems
• Regulators & Payers
• Pharma & Life Sciences
• Patient Advocacy Groups
• Startups & Emerging Tech
• Medtech, Healthtech & BigTech
• Advisory Board Roles
• AI-powered Clinical Trials
• Clinical & Scientific Validation
• AI Agents for Consumer Health
• Medical Devices & Patient Apps
• Digital Health & Remote Monitoring
• Investment Strategy & Due Diligence
• Product Development & GTM Strategy
With us, you’re not just building a product — you’re building to stay relevant in the future of human-AI collaboration. We make sure your solutions are clinically safe, market-proven, and commercially unshakeable.
“AI isn’t about brilliant algorithms. It’s about basic ones used brilliantly.”
This mantra shapes every engagement. We don’t chase novelty for its own sake; we build what’s safe, what works, and what holds up in the real world of patients and clinicians.
“Dr. Lahav rewires how you think. Each conversation brings clarity, foresight, and strategic lift. His instincts on partnerships and market shifts shape the direction we’re heading.”
John Gannon, President & CEO, Blue Spark Tech
”Amir’s network is a strategic weapon. His personal connections with key decision-makers, combined with SkyMedAI’s team, translate access into crucial intel and real value—exactly what founders need.”
Teri Chou, PhD, Founder & CEO, Modus Health
”As a serial founder, I’ve worked with many advisors. Amir stands out for his strategic clarity, scientific depth, and market instinct that drive real results. He is the collaborator you need by your side when engaging investors.”
David Fox, Angel Investor, Co-founder, Modality.AI
”Dr. Lahav is among the best clinical advisors I’ve worked with. He sees patterns in nontraditional datasets and turns them into strategic advantages. He crafts narratives that give founders the confidence to engage clinicians, investors, and partners.”
Micha Breakstone, PhD, Co-Founder & CEO, Somite
”Most FDA rejections stem from poor strategy and communication failures. Amir’s special skill is precisely anticipating what regulators care about: what they need to hear, the data they must see, and how to secure approvals for digital health and AI products.”
Jonathan Helfgott, Former FDA Senior Leadership
”Amir and SkyMedAI were outstanding. Their sophisticated strategy, sharp attention to detail, and expert product positioning pushed us to think bigger. Their coaching completely changed how we showed up in the US market to secure partnerships.”
Roy Tal, Founder & CEO, Solo AI
↓ Click any card to explore ↓